Phase II study of sunitinib malate (SU11248) in bevacizumab-refractory metastatic renal cell carcinoma (MRCC)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Rini, BI; George, DJ; Michaelson, MD; Rosenberg, JE; Bukowski, RM; Sosman, JA; Stadler, WM; Margolin, K; Hutson, TE; Baum, CM

Published Date

  • January 1, 2006

Published In

Volume / Issue

  • 17 /

Start / End Page

  • 144 - 144

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 30th Congress of the European-Society-for-Medical-Oncology

Conference Location

  • Istanbul, TURKEY

Conference Start Date

  • September 29, 2006

Conference End Date

  • October 3, 2006